SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-042481
Filing Date
2015-07-14
Accepted
2015-07-14 17:21:41
Documents
5
Period of Report
2015-08-24
Effectiveness Date
2015-07-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A v415118_def14a.htm DEF 14A 202479
2 GRAPHIC v415118_pc-1.jpg GRAPHIC 639872
3 GRAPHIC v415118_pc-2.jpg GRAPHIC 487054
4 GRAPHIC line.gif GRAPHIC 43
5 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-15-042481.txt   1756960
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10113 | Film No.: 15987918
SIC: 2834 Pharmaceutical Preparations